TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Arctic Bioscience AS
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
33,750
|
34,272
|
21,515 |
| Financial expenses |
2,348
|
4
|
2,121 |
| Earnings before taxes |
-45,515
|
-34,024
|
-42,580 |
| Total assets |
300,252
|
327,702
|
341,475 |
| Current assets |
133,155
|
198,327
|
266,934 |
| Current liabilities |
39,646
|
40,422
|
20,921 |
| Equity capital |
258,557
|
287,280
|
320,554 |
| - share capital |
2,537
|
2,438
|
2,430 |
| Employees (average) | 17 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.1%
|
87.7%
|
93.9% |
| Turnover per employee | 2,016 | ||
| Profit as a percentage of turnover |
-134.9%
|
-99.3%
|
-197.9% |
| Return on assets (ROA) |
-14.4%
|
-10.4%
|
-11.8% |
| Current ratio |
335.9%
|
490.6%
|
1275.9% |
| Return on equity (ROE) |
-17.6%
|
-11.8%
|
-13.3% |
| Change turnover |
-522
|
12,757
|
1,018 |
| Change turnover % |
-2%
|
59% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.